MetaCap

Axonex AI Group (AXNX) vs Quhuo (QH)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Quhuo is the larger company by market cap ($8.4 million vs $5.3 million), about 1.6 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AXNX+16.92%QH-12.57%
+64%+10%-45%
Oct 13, 20261 yearNov 20, 2026
AXNX+76.17%QH-8.66%
+134%+54%-27%
Oct 12, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AXNX versus QH key metrics
MetricAXNXQH
Share price$0.8301$3.06
Market cap$5.28M$8.42M
1-day change-8.28%-1.29%
EPS (TTM)$-10.37$-489.48
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$361.20M
Revenue growth (YoY)—-13.47%
Net income (latest FY)$-10.31M$-21.37M
Gross margin—0.49%
Operating margin—-7.05%
Net margin—-5.92%
52-week high$18.35$12.81
52-week low$0.68$0.017
Distance from 52-week high-95.48%-76.11%
Analyst consensushold—
Average volume2.01M8.02K
Shares outstanding6.08M2.75M
Employees797474
SectorConsumer DiscretionaryConsumer Discretionary
IndustryBusiness ServicesBusiness Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Axonex AI Group

AXNX stock →

Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI.

Consumer Discretionary · Business Services · 797 employees

About Quhuo

QH stock →

Quhuo Limited, through its subsidiaries, provides workforce operational solutions in the People's Republic of China. It operates in two segments, On-Demand Delivery Solutions and Others.

Consumer Discretionary · Business Services · 474 employees

AXNX vs QH FAQ

Which is bigger, Axonex AI Group or Quhuo?

Quhuo (QH) is larger, with a market capitalization of $8.42M compared with $5.28M for Axonex AI Group (AXNX).

Are Axonex AI Group and Quhuo in the same industry?

Yes. Both are classified in the Business Services industry within the Consumer Discretionary sector.

More comparisons